Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Índice de contenido
Ver el documentoForeword
Ver el documentoAcknowledgements
Abrir esta carpeta y ver su contenidoIntroduction
Cerrar esta carpetaChapter 1. Selection
Cerrar esta carpetaObjective of selection
Ver el documentoAvoid drugs of no therapeutic interest
Ver el documentoReduce the number of drugs
Ver el documentoIncrease the efficiency of available drugs
Abrir esta carpeta y ver su contenidoThe criterion of economic efficiency
Ver el documentoSelection: important points
Abrir esta carpeta y ver su contenidoChapter 2. Procurement
Abrir esta carpeta y ver su contenidoChapter 3. Distribution
Abrir esta carpeta y ver su contenidoChapter 4. Prescribing
Abrir esta carpeta y ver su contenidoSummary: contributions and limitations of the economic approach
Ver el documentoReferences
Ver el documentoSelected WHO publications of related interest
Ver el documentoBack cover
 

Avoid drugs of no therapeutic interest

Of all drugs available, some are ineffective or useless, and others are dangerous but have at least one equivalent safe alternative. Drugs that are of no therapeutic use cannot be justified on either medical or economic grounds. Therefore, these drugs should be eliminated by a general ban. In 1982 Bangladesh banned 1707 products, fully one-third of its total consumption. Of the banned products, 305 were altogether harmful, 134 associations (associations of components offering no additional therapeutic value as compared with their components taken separately) required reformulation and 1268 drugs were useless. Industrial or political problems engendered by such bans must be taken into consideration, but without compromising the goal of the ban.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013